@article{10767, keywords = {Humans, *Anti-Arrhythmia Agents/therapeutic use, *Anticonvulsants/therapeutic use, Electronics, Primary health care, Retrospective Studies, *Neoplasms/drug therapy, *Sodium Channel Blockers/therapeutic use, Breast tumours, Clinical pharmacology, epilepsy, Oncology}, author = {C. Fairhurst and F. Martin and I. Watt and M. Bland and T. Doran and W. Brackenbury}, title = {Sodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data}, year = {2023}, journal = {BMJ Open}, volume = {13}, edition = {2023/02/04}, number = {2}, pages = {e064376}, isbn = {2044-6055}, doi = {10.1136/bmjopen-2022-064376}, note = {2044-6055 Fairhurst, Caroline Martin, Fabiola Watt, Ian Bland, Martin Doran, Tim Brackenbury, William John Orcid: 0000-0001-6882-3351 G1000508/Medical Research Council/United Kingdom Wellcome Trust/United Kingdom Journal Article Research Support, Non-U.S. Gov't England BMJ Open. 2023 Feb 3;13(2):e064376. doi: 10.1136/bmjopen-2022-064376.}, language = {eng}, }